Dr. Scott Aronson, MD

NPI: 1285655274
Total Payments
$8,282
2024 Payments
$1,658
Companies
43
Transactions
573
Medicare Patients
2,395
Medicare Billing
$328,530

Payment Breakdown by Category

Food & Beverage$8,256 (99.7%)
Other$20.00 (0.2%)
Education$6.61 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,256 571 99.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20.00 1 0.2%
Education $6.61 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,356 166 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,034 85 $0 (2024)
Janssen Biotech, Inc. $687.26 47 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $615.66 45 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $591.23 36 $0 (2024)
PFIZER INC. $436.28 32 $0 (2024)
Allergan Inc. $434.98 29 $0 (2019)
Intercept Pharmaceuticals, Inc. $186.28 12 $0 (2024)
Braintree Laboratories, Inc. $170.39 11 $0 (2024)
QOL Medical, LLC $152.70 9 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,658 99 ABBVIE INC. ($544.41)
2023 $1,010 67 AbbVie Inc. ($328.26)
2022 $1,005 73 ABBVIE INC. ($326.82)
2021 $1,118 82 AbbVie Inc. ($308.72)
2020 $473.85 34 AbbVie Inc. ($118.15)
2019 $982.61 84 AbbVie, Inc. ($251.37)
2018 $932.66 71 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($176.55)
2017 $1,102 63 AbbVie, Inc. ($344.31)

All Payment Transactions

573 individual payment records from CMS Open Payments — Page 1 of 23

Date Company Product Nature Form Amount Type
12/18/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $18.29 General
Category: Immunology
12/18/2024 ABBVIE INC. VIBERZI (Drug), CREON Food and Beverage In-kind items and services $9.57 General
Category: GASTROENTEROLOGY
12/16/2024 ABBVIE INC. CREON (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $20.00 General
Category: ENDOCRINOLOGY
12/11/2024 SANOFI-AVENTIS U.S. LLC REZUROCK (Drug) Food and Beverage In-kind items and services $20.70 General
Category: Oncology
12/10/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.18 General
Category: Immunology
12/03/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $16.18 General
Category: GASTROENTEROLOGY
11/27/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $23.56 General
Category: LIVER DISEASE
11/25/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $13.48 General
Category: Hepatology / Gastroenterology
11/22/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $19.85 General
Category: Immunology
11/20/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $19.93 General
Category: GI
11/15/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $20.64 General
Category: GI
11/13/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $22.58 General
Category: GASTROENTEROLOGY
11/12/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.57 General
Category: IMMUNOLOGY
11/11/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $18.01 General
Category: IMMUNOLOGY
10/31/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $16.42 General
Category: INTERNAL MEDICINE
10/24/2024 Lilly USA, LLC OMVOH (Drug) Food and Beverage In-kind items and services $24.46 General
Category: Immunology
10/23/2024 ABBVIE INC. LINZESS (Drug) Food and Beverage In-kind items and services $13.35 General
Category: GASTROENTEROLOGY
10/21/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.04 General
Category: Immunology
10/18/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $13.01 General
Category: IMMUNOLOGY
10/16/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $11.43 General
Category: IMMUNOLOGY
10/14/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.11 General
Category: Immunology
10/08/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $17.54 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
09/26/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $17.88 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
09/25/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $19.64 General
Category: GASTROENTEROLOGY
09/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $14.75 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 624 765 $472,764 $80,435
2022 10 620 888 $475,455 $93,172
2021 11 648 922 $397,460 $96,172
2020 10 503 726 $278,390 $58,751
Total Patients
2,395
Total Services
3,301
Medicare Billing
$328,530
Procedure Codes
44

All Medicare Procedures & Services

44 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 188 264 $92,136 $26,039 28.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 69 69 $125,235 $10,180 8.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 90 109 $25,615 $7,634 29.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 60 60 $26,400 $7,173 27.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 27 31 $14,570 $4,699 32.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 48 48 $76,560 $4,560 6.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 21 62 $14,260 $4,066 28.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 18 18 $34,155 $3,959 11.6%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 19 19 $32,186 $3,640 11.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 35 35 $12,320 $3,078 25.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 13 13 $7,684 $2,462 32.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $8,211 $1,779 21.7%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 23 24 $3,432 $1,166 34.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 217 396 $83,568 $39,764 47.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 110 110 $28,240 $13,149 46.6%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 77 77 $139,445 $9,259 6.6%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 36 36 $70,268 $7,989 11.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 58 61 $83,560 $5,627 6.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 30 93 $22,275 $5,536 24.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 50 67 $9,120 $3,653 40.1%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 16 16 $28,482 $3,212 11.3%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 12 18 $4,820 $2,710 56.2%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 14 14 $5,678 $2,274 40.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 211 388 $67,900 $39,368 58.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 130 130 $26,000 $18,145 69.8%

About Dr. Scott Aronson, MD

Dr. Scott Aronson, MD is a Gastroenterology healthcare provider based in Somerset, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285655274.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Aronson, MD has received a total of $8,282 in payments from pharmaceutical and medical device companies, with $1,658 received in 2024. These payments were reported across 573 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,256).

As a Medicare-enrolled provider, Aronson has provided services to 2,395 Medicare beneficiaries, totaling 3,301 services with total Medicare billing of $328,530. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Somerset, NJ
  • Active Since 07/22/2006
  • Last Updated 05/09/2016
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1285655274

Products in Payments

  • XIFAXAN (Drug) $878.93
  • LINZESS (Drug) $603.01
  • STELARA (Biological) $587.04
  • RINVOQ (Biological) $531.40
  • Humira (Biological) $489.90
  • Linzess (Drug) $483.56
  • XELJANZ (Drug) $409.97
  • HUMIRA (Biological) $340.91
  • SKYRIZI (Biological) $244.44
  • OCALIVA (Drug) $186.28
  • ENTYVIO (Biological) $178.56
  • Creon (Drug) $166.31
  • SUCRAID (Drug) $141.16
  • VIBERZI (Drug) $132.45
  • Amitiza (Drug) $128.44
  • CREON (Drug) $124.23
  • SUTAB (Drug) $124.01
  • GATTEX (Drug) $121.73
  • IBSRELA (Drug) $116.05
  • MAVYRET (Drug) $115.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Somerset